Table 1 Demographic and perioperative variables among 41 patients who underwent hepatobiliary surgery
From: Inflammation and pro-resolution inflammation after hepatobiliary surgery
Variable | Result |
|---|---|
Age, years [IQR] | 57 [48.5–67.5] |
Sex, female/male, n (%) | 22 (54)/19 (46) |
Height, cm [IQR] | 170 [163–176.5] |
Weight, kg [IQR] | 78 [64.75–90.4] |
ASA physical status, n (%) | |
1 or 2 | 1 (2) |
3 or 4 | 40 (98) |
Comorbidities, yes/no, n (%) | |
Coronary artery disease | 1 (2)/40 (98) |
Hypertension | 11 (27)/30 (73) |
Hyperlipemia | 4 (10)/37 (90) |
Diabetes mellitus | 3 (7)/38 (93) |
Hypothyroidism | 4 (10)/37 (90) |
Medications, n (%) | |
Statins | 5 (12)/36 (88) |
Antihypertensives | 13 (31)/28 (69) |
Antidiabetic drugs | 3 (7)/38 (93) |
Non-steroidal anti-inflammatory drugs | 2 (5)/39 (95) |
Histology, n (%) | |
Cholangiocarcinoma | 25 (61) |
Gallbladder carcinoma | 4 (10) |
Colorectal carcinoma | 2 (5) |
Other | 10 (24) |
Preoperative chemotherapy, yes/no, n (%) | 27 (66)/19 (34) |
Type of surgery, n (%) | |
Liver resection | 40 (98) |
Pancreatectomy | 1 (2) |
Duration of surgery (min), median [range] | 293 [219.5–340.5] |